Invasive pneumococcal disease 3 years after introduction of 10-valent pneumococcal conjugate vaccine, the Netherlands
Response on pneumococcal vaccine in preterm infants after neutral and acidic oligosaccharides supplementation
Increased incidence of serotype-1 invasive pneumococcal disease in young female adults in The Netherlands
Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands
Direct comparison of immunogenicity induced by 10- or 13-valent pneumococcal conjugate vaccine around the 11-month booster in Dutch infants
Rijksinstituut voor Volksgezondheid
Rijksinstituut voor Volksgezondheid